Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety of CERE-120 (AAV2-NTN) in Subjects With Idiopathic Parkinson's Disease

This study has been completed.
Sponsor:
Information provided by:
Ceregene
ClinicalTrials.gov Identifier:
NCT00252850
First received: November 11, 2005
Last updated: March 25, 2009
Last verified: March 2009